好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Freezing of Gait in Patients with Parkinson's Disease and Globus Pallidus Internus Deep Brain Stimulation
Movement Disorders
P2 - Poster Session 2 (8:00 AM-9:00 AM)
5-027

To determine the one-year effects of Globus Pallidus Internus (GPi) deep brain stimulation (DBS) on freezing of gait (FOG) in Parkinson's disease (PD) using motor examination and patient-reported outcomes.

FOG has been well-studied in the context of subthalamic nucleus (STN) DBS; however, the effects of GPi DBS on FOG are not as well established.

We retrospectively analyzed PD patients from Emory clinical database who received bilateral GPi DBS (2017–2022) and had MDS-UPDRS Parts 2 and 3 at baseline and approximately 12 months post-DBS. Parts 2 (patient-reported) and 3 (examination) include items assessing freezing (2.13, 3.11). MDS-UPDRS scores were compared between med-off at baseline and med-off/stim-on at follow-up, and between med-on at baseline and med-on/stim-on at follow-up using paired t-tests.

Twenty-nine patients (11 females, mean age 65.7 ± 5.4 years, disease duration 13.6 ± 5.3 years) were followed for 13.7 ± 1.8 months post-DBS.

The MDS-UPDRS Part 2 total score decreased significantly at 12 months post-DBS (18.2 vs. 14.6; p = 0.04, n = 20), but there was no significant difference in the Part 2 freezing score (1.0 vs. 1.1; p = 0.83, n=20).

The MDS-UPDRS Part 3 total score improved significantly with GPi DBS in both med-off (45.8 vs. 23.1; p < 0.01, n = 29) and med-on conditions (18.4 vs. 12.8; p < 0.01, n = 20). The Part 3 freezing exam score was significantly reduced in the med-off condition (0.8 vs. 0.3; p = 0.01, n = 29), while no significant difference was observed in the med-on condition (0.1 vs. 0.3; p = 0.33, n = 20).

GPi DBS improves FOG in the short-term follow-up (~1 year) during the med-off state. However, this improvement is not observed in the med-on state or in patient-reported outcomes despite overall improvement in motor function.

Authors/Disclosures
Osman Corbali, MD
PRESENTER
Mr. Corbali has nothing to disclose.
Svjetlana Miocinovic, MD, PhD (Emory University) Dr. Miocinovic has nothing to disclose.